DOCSLIB.ORG

Rab35-Regulated Lipid Turnover by Myotubularins Represses Mtorc1 Activity and Controls Myelin Growth

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rab35-Regulated Lipid Turnover by Myotubularins Represses Mtorc1 Activity and Controls Myelin Growth Rab35-regulated lipid turnover by myotubularins represses mTORC1 activity and controls myelin growth Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry and Pharmacy of the Freie Universität Berlin by Linda Sawade from Berlin, Germany 2019 Period of doctorate studies: November 2013 to August 2019 Supervisor: Prof. Dr. Volker Haucke Institute: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin 1st Reviewer: Prof. Dr. Volker Haucke 2nd Reviewer: Prof. Dr. Stephan Sigrist Date of defense: 29.10.2019 Affidavit I declare that my PhD thesis at hand has been written independently and with no other sources and aids than quoted. Berlin, August the 13th, 2019 Acknowledgements First of all, I would like to express my deep gratitude to my supervisor, Prof. Dr. Volker Haucke, for his guidance, support and constant motivation throughout my PhD studies, which were crucial for the success of this project. I owe special thanks to our collaboration partners Prof. Dr. Alessandra Bolino (INSPE, Milan, Italy), and her team Federica Grandi, Marianna Mignanelli, and Roberta Di Guardo who performed great work with the Schwann cell-specific Rab35 knockout mice and provided us the MTMR2 shRNA. I am also very grateful to Prof. Dr. Arnaud Echard (Pasteur-Institut, Paris, France) who provided us with the GFP-Rab35endo KI HeLa cells, and especially the Rab35Fl/Fl mice for conditional gene knockout. Many thanks also to his team, Dr. Kerstin Klinkert and Dr. Francina Langa Vives, as well as to Prof. Dr. Stephen Shaw (formerly: NIH, Bethesda, USA) and Dr. Genaro Patiño-López (formerly: NIH; now: Hospital Infantil de México, Ciudad de México, México), who generated these animals. Furthermore, I would like to thank Prof. Dr. Cesare Montecucco and his team (University of Padova, Italy), especially Dr. Samuele Negro, for the training in preparation of sciatic nerves and Schwann cell cultures in vitro. Special thanks also to Dr. Eberhard Krause, the former head of the mass spectrometry facility at the FMP-Berlin (Germany), and his team, especially Heike Stephanowitz, for the BioID-mass spectrometry. Many thanks to Dr. Dmytro Puchkov, the head of the electron microscopy facility, and his team for the ultrastructural analysis of the conditional Rab35 knockout neurons in culture. I would also like to thank Dr. Burkhard Wiesner, Jenny Eichhorst and Dr. Martin Lehmann from the Imaging facility (FMP Berlin), who provided us with terrific microscopes, technical knowledge and support. I am also very grateful for financial funding by the Grant SFB 958 (Deutsche Forschungsgemeinschaft). I would like to thank the secretary office, Heidemarie Petschick and Alexandra Chylla, who were always helpful and supportive, as well as to the FMP-IT, especially Alexander Heyne. Special thanks to Prof. Dr. Tanja Maritzen for the management and supervision of animal experimental administration, and to the animal house facility, Dr. Natali Wisbrun and her team Eva Lojek, Sina Scholz and Jeanette Unasch. Furthermore, I would like to thank the technicians of the Haucke lab: Delia Löwe, especially for the management of the common cell and neuron culture. Uwe Fink for his skills and advices regarding protein purifications. Claudia Schmidt for providing help whenever required. Silke Zillmann for the ordering management and genotypings, as well as Sophia Griese. Many thanks to Sabine Hahn, for the support with astrocytic culture preparations, and 3 especially for the time when I joined the lab as an unexperienced undergraduate student. And special thanks to Maria Mühlbauer for the technical assistance and her great support in this project. I owe special thanks to Dr. Natalie Kaempf and Dr. Domenico Azarnia Tehran for fruitful discussions, advices and especially their kind support in many ways. I thank Dr. Natalia Kononenko, who supervised me as an undergraduate and during my first year as a PhD, and Dr. Tania Lopez Hernandez and Dennis Vollweiter for introducing me into the wonderful world of astrocytes and “R”, respectively. Thanks to Dr. Wen-Ting Lo for his advices regarding affinity purifications. Thanks also to our former lab member Katarina Ketel, who worked on MTM1, and thus, already obtained the basic constructs which made the work with this protein family a bit easier. And thanks to all other past and present members of the Haucke lab I’ve got to know over the years and who contributed to a joyful atmosphere in the lab: Jelena Bacetic, Marietta Bergmann, Svenja Bolz, Caroline Bruns, Gabrielle Capin, Gala Claßen, Katrin Diesenberg, Michael Ebner, Marielle Eichhorn-Grünig, Fabian Feutlinske, Paula Samsó Ferre, Niclas Gimber, Marine Gil, Hannes Gonschoir, Claudia Gras, Manuel Hessenberger, Lennart Hoffmann, Burkhard Jakob, Wonyul Jang, Maria Jäpel, Christina Kath, Philipp Koch, Gaga Kochlamazashvili, Seong Joo Koo, Michael Krauß, Marijn Kuijpers, André Lampe, Gregor Lichtner, Guan-Ting Liu, Fabian Lukas, Albert Mackintosh, Marta Maglione, Charles Malek, Andrea Marat, Kristine Oevel, Christoph Ott, Filiz Sila Rizalar, Giulia Russo, Hannah Schachtner, Christopher Schmied, Jan Schmoranzer, Irene Schütz, Kyungyuen Song, Tolga Soykan, Wiebke Stahlschmidt, Anela Vukoja, Alexander Wallroth, Alexander Walter, Haibin Wang, Anna Wawrzyniak and Mirjana Weimershaus. Finally, and most important, I owe my deepest gratitude to my family for all their support throughout my life, and to Thomas Lenz who especially backed me up over the last years. 4 I Table of content I Table of content……………………………………………………………………………….5 II Summary………………………………………………………………………......................9 III Zusammenfassung…………………………………………………………………………11 1. Introduction………………………………………………………………………………. 13 1.1 Myelination of the vertebrate nervous system……………………………………..13 1.2 Myelinating glial cells……………………………………………………………..13 1.3 The function of myelination…………………………………….............................16 1.4 Myelin structure………………………………………...........................................17 1.5 Cell signaling pathways in myelination……………………………………….......20 1.5.1 mTORC1 is a central regulator of myelination…………………………..23 1.5.1.1 Canonical pathways that regulate mTORC1 activity…………..23 1.5.1.2 Regulation of mTORC1 activity by PI(3)-phosphates………...24 1.5.1.3 mTORC1 controls the metabolic switch of cells……………….26 1.5.1.4 Altered mTORC1 activity leads to impaired myelin homeostasis………………………………………………….. 27 1.6 Myelin in pathological conditions…………………………………………............29 1.6.1 Myotubularins are crucially involved in myelination……………………31 1.6.1.1 The family of myotubularin-related lipid phosphatases…..…...31 1.6.1.2 CMT-associated MTMRs……………………………………...34 1.7 The small GTPase Rab35 is implicated in myelination…………………………....37 1.8 Aims……………………………………………………………………………… 41 2. Material and Methods………………………………………………………………….…...42 2.1 Material……………………………………………………………………….…...42 2.1.1 Chemicals and consumables…………………………..………………... 42 2.1.2 Solutions, media and buffers……………………………….…………....42 2.1.3 Enzymes………………………………………………………………....47 2.1.4 Kits……………………………………………………………………....48 2.1.5 Standards for gel electrophoresis………………………………………...48 2.1.6 DNA oligonucleotides……………………………………………….......48 2.1.7 RNA oligonucleotides…………………………………………………...49 2.1.7.1 siRNAs………………………………………...........................49 2.1.7.2 shRNAs………………………………………..........................50 2.1.8 DNA-plasmids and expression vectors……………………………….....50 2.1.9 Antibodies and probes………………………………………...................52 2.1.9.1 Primary antibodies………………………………………......... 52 2.1.9.2 Secondary antibodies………………………………………..... 53 2.1.9.3 Probes……………………………………….............................54 2.1.10 Inhibitors……………………………………….....................................54 2.1.11 Mammalian cell lines………………………………………..................55 2.1.12 Bacteria strains………………………………………............................55 2.1.13 Mouse strains………………………………………..............................55 2.1.14 Software………………………………………......................................56 5 2.1.15 Suppliers……………………………………….................................... 57 2.2 Methods………………………………………………………….......................... 58 2.2.1 Molecular Biology Methods………………………………………......... 58 2.2.1.1 Preparative and analytical Polymerase chain reaction (PCR)….58 2.2.1.2 Genotyping of transgenic mice ………………………………..60 2.2.1.3 Agarose gel electrophoresis……………………………………62 2.2.1.4 Purification of DNA from agarose gels……………………….. 62 2.2.1.5 DNA-restriction digest.……………………………………..... 62 2.2.1.6 Ligation……………………………………………………......63 2.2.1.7 Transformation of chemically competent E. coli……………....63 2.2.1.8 Preparation of bacterial glycerol stocks……………………….64 2.2.1.9 Cultivation of transformed bacteria…………………………....64 2.2.1.10 Isolation of plasmid DNA…………………………………….64 2.2.1.11 Spectrophotometric determination of DNA concentration…...65 2.2.1.12 Sequencing of DNA………………………………………….65 2.2.1.13 Isolation of genomic DNA…………………………………...65 2.2.2 Cell biology methods……………………………………………………66 2.2.2.1 Cultivation and passaging of mammalian cell lines………….. 66 2.2.2.2 Transfection of mammalian cell lines using JetPrime…………67 2.2.2.3 Transfection of mammalian cell lines using calcium phosphate.68 2.2.2.4 Production of lentiviral particles……………………………… 68 2.2.2.5 Preparation of primary cell cultures from mice………………. 70 2.2.2.5.1 Primary neuronal cultures……………………………71 2.2.2.5.2 Primary astrocytic cultures…………………………..72 2.2.2.5.3 Primary oligodendrocytic (precursor) cell cultures…..73 2.2.2.5.4 Primary Schwann
Load more

Recommended publications
  • Mouse Germ Line Mutations Due to Retrotransposon Insertions Liane Gagnier1, Victoria P
    Gagnier et al. Mobile DNA (2019) 10:15 https://doi.org/10.1186/s13100-019-0157-4 REVIEW Open Access Mouse germ line mutations due to retrotransposon insertions Liane Gagnier1, Victoria P. Belancio2 and Dixie L. Mager1* Abstract Transposable element (TE) insertions are responsible for a significant fraction of spontaneous germ line mutations reported in inbred mouse strains. This major contribution of TEs to the mutational landscape in mouse contrasts with the situation in human, where their relative contribution as germ line insertional mutagens is much lower. In this focussed review, we provide comprehensive lists of TE-induced mouse mutations, discuss the different TE types involved in these insertional mutations and elaborate on particularly interesting cases. We also discuss differences and similarities between the mutational role of TEs in mice and humans. Keywords: Endogenous retroviruses, Long terminal repeats, Long interspersed elements, Short interspersed elements, Germ line mutation, Inbred mice, Insertional mutagenesis, Transcriptional interference Background promoter and polyadenylation motifs and often a splice The mouse and human genomes harbor similar types of donor site [10, 11]. Sequences of full-length ERVs can TEs that have been discussed in many reviews, to which encode gag, pol and sometimes env, although groups of we refer the reader for more in depth and general infor- LTR retrotransposons with little or no retroviral hom- mation [1–9]. In general, both human and mouse con- ology also exist [6–9]. While not the subject of this re- tain ancient families of DNA transposons, none view, ERV LTRs can often act as cellular enhancers or currently active, which comprise 1–3% of these genomes promoters, creating chimeric transcripts with genes, and as well as many families or groups of retrotransposons, have been implicated in other regulatory functions [11– which have caused all the TE insertional mutations in 13].
    [Show full text]
  • Regulation of Cdc42 and Its Effectors in Epithelial Morphogenesis Franck Pichaud1,2,*, Rhian F
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs217869. doi:10.1242/jcs.217869 REVIEW SUBJECT COLLECTION: ADHESION Regulation of Cdc42 and its effectors in epithelial morphogenesis Franck Pichaud1,2,*, Rhian F. Walther1 and Francisca Nunes de Almeida1 ABSTRACT An overview of Cdc42 Cdc42 – a member of the small Rho GTPase family – regulates cell Cdc42 was discovered in yeast and belongs to a large family of small – polarity across organisms from yeast to humans. It is an essential (20 30 kDa) GTP-binding proteins (Adams et al., 1990; Johnson regulator of polarized morphogenesis in epithelial cells, through and Pringle, 1990). It is part of the Ras-homologous Rho subfamily coordination of apical membrane morphogenesis, lumen formation and of GTPases, of which there are 20 members in humans, including junction maturation. In parallel, work in yeast and Caenorhabditis elegans the RhoA and Rac GTPases, (Hall, 2012). Rho, Rac and Cdc42 has provided important clues as to how this molecular switch can homologues are found in all eukaryotes, except for plants, which do generate and regulate polarity through localized activation or inhibition, not have a clear homologue for Cdc42. Together, the function of and cytoskeleton regulation. Recent studies have revealed how Rho GTPases influences most, if not all, cellular processes. important and complex these regulations can be during epithelial In the early 1990s, seminal work from Alan Hall and his morphogenesis. This complexity is mirrored by the fact that Cdc42 can collaborators identified Rho, Rac and Cdc42 as main regulators of exert its function through many effector proteins.
    [Show full text]
  • Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2010 Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis Ryan Fassnacht Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Physiology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2246 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Ryan C. Fassnacht 2010 All Rights Reserved Molecular Mechanisms Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Ryan Christopher Fassnacht, B.S. Hampden Sydney University, 2005 M.S. Virginia Commonwealth University, 2010 Director: Valeria Mas, Ph.D., Associate Professor of Surgery and Pathology Division of Transplant Department of Surgery Virginia Commonwealth University Richmond, Virginia July 9, 2010 Acknowledgement The Author wishes to thank his family and close friends for their support. He would also like to thank the members of the molecular transplant team for their help and advice. This project would not have been possible with out the help of Dr. Valeria Mas and her endearing
    [Show full text]
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • Ingenuity Pathway Analysis of Differentially Expressed Genes Involved in Signaling Pathways and Molecular Networks in Rhoe Gene‑Edited Cardiomyocytes
    INTERNATIONAL JOURNAL OF MOleCular meDICine 46: 1225-1238, 2020 Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene‑edited cardiomyocytes ZHONGMING SHAO1*, KEKE WANG1*, SHUYA ZHANG2, JIANLING YUAN1, XIAOMING LIAO1, CAIXIA WU1, YUAN ZOU1, YANPING HA1, ZHIHUA SHEN1, JUNLI GUO2 and WEI JIE1,2 1Department of Pathology, School of Basic Medicine Sciences, Guangdong Medical University, Zhanjiang, Guangdong 524023; 2Hainan Provincial Key Laboratory for Tropical Cardiovascular Diseases Research and Key Laboratory of Emergency and Trauma of Ministry of Education, Institute of Cardiovascular Research of The First Affiliated Hospital, Hainan Medical University, Haikou, Hainan 571199, P.R. China Received January 7, 2020; Accepted May 20, 2020 DOI: 10.3892/ijmm.2020.4661 Abstract. RhoE/Rnd3 is an atypical member of the Rho super- injury and abnormalities, cell‑to‑cell signaling and interaction, family of proteins, However, the global biological function and molecular transport. In addition, 885 upstream regulators profile of this protein remains unsolved. In the present study, a were enriched, including 59 molecules that were predicated RhoE‑knockout H9C2 cardiomyocyte cell line was established to be strongly activated (Z‑score >2) and 60 molecules that using CRISPR/Cas9 technology, following which differentially were predicated to be significantly inhibited (Z‑scores <‑2). In expressed genes (DEGs) between the knockout and wild‑type particular, 33 regulatory effects and 25 networks were revealed cell lines were screened using whole genome expression gene to be associated with the DEGs. Among them, the most signifi- chips. A total of 829 DEGs, including 417 upregulated and cant regulatory effects were ‘adhesion of endothelial cells’ and 412 downregulated, were identified using the threshold of ‘recruitment of myeloid cells’ and the top network was ‘neuro- fold changes ≥1.2 and P<0.05.
    [Show full text]
  • Investigation of Candidate Genes and Mechanisms Underlying Obesity
    Prashanth et al. BMC Endocrine Disorders (2021) 21:80 https://doi.org/10.1186/s12902-021-00718-5 RESEARCH ARTICLE Open Access Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules G. Prashanth1 , Basavaraj Vastrad2 , Anandkumar Tengli3 , Chanabasayya Vastrad4* and Iranna Kotturshetti5 Abstract Background: Obesity associated type 2 diabetes mellitus is a metabolic disorder ; however, the etiology of obesity associated type 2 diabetes mellitus remains largely unknown. There is an urgent need to further broaden the understanding of the molecular mechanism associated in obesity associated type 2 diabetes mellitus. Methods: To screen the differentially expressed genes (DEGs) that might play essential roles in obesity associated type 2 diabetes mellitus, the publicly available expression profiling by high throughput sequencing data (GSE143319) was downloaded and screened for DEGs. Then, Gene Ontology (GO) and REACTOME pathway enrichment analysis were performed. The protein - protein interaction network, miRNA - target genes regulatory network and TF-target gene regulatory network were constructed and analyzed for identification of hub and target genes. The hub genes were validated by receiver operating characteristic (ROC) curve analysis and RT- PCR analysis. Finally, a molecular docking study was performed on over expressed proteins to predict the target small drug molecules. Results: A total of 820 DEGs were identified between
    [Show full text]
  • Cell Reprogramming Technologies for Treatment And
    CELL REPROGRAMMING TECHNOLOGIES FOR TREATMENT AND UNDERSTANDING OF GENETIC DISORDERS OF MYELIN by ANGELA MARIE LAGER Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Thesis advisor: Paul J Tesar, PhD Department of Genetics and Genome Sciences CASE WESTERN RESERVE UNIVERSITY May 2015 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Angela Marie Lager Candidate for the Doctor of Philosophy degree*. (signed) Ronald A Conlon, PhD (Committee Chair) Paul J Tesar, PhD (Advisor) Craig A Hodges, PhD Warren J Alilain, PhD (date) 31 March 2015 *We also certify that written approval has been obtained from any proprietary material contained therein. TABLE OF CONTENTS Table of Contents……………………………………………………………………….1 List of Figures……………………………………………………………………………4 Acknowledgements……………………………………………………………………..7 Abstract…………………………………………………………………………………..8 Chapter 1: Introduction and Background………………………………………..11 1.1 Overview of mammalian oligodendrocyte development in the spinal cord and myelination of the central nervous system…………………..11 1.1.1 Introduction……………………………………………………..11 1.1.2 The establishment of the neuroectoderm and ventral formation of the neural tube…………………………………..12 1.1.3 Ventral patterning of the neural tube and specification of the pMN domain in the spinal cord……………………………….15 1.1.4 Oligodendrocyte progenitor cell production through the process of gliogenesis ………………………………………..16 1.1.5 Oligodendrocyte progenitor cell to oligodendrocyte differentiation…………………………………………………...22
    [Show full text]
  • Differentially Expressed on Collagen Networks 1, 2, 10 © 2000-2009 Ingenuity Systems, Inc. All Rights Reserved. Symbol Entrez
    Differentially expressed on collagen Networks 1, 2, 10 © 2000-2009 Ingenuity Systems, Inc. All rights reserved. Symbol Entrez Gene Name Affymetrix Fold Change Location Family ALDH1A3 aldehyde dehydrogenase 1 family, member A3 203180_at -5.43125168 Cytoplasm enzyme 209772_s_ Plasma CD24 CD24 molecule at -4.32890229 Membrane other HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 204130_at -4.1099197 Cytoplasm enzyme Plasma AMOTL2 angiomotin like 2 203002_at -2.82872773 Membrane other transcription DLX2 distal-less homeobox 2 207147_at -2.74996362 Nucleus regulator 221215_s_ RIPK4 receptor-interacting serine-threonine kinase 4 at -2.56556472 Nucleus kinase PLK2 polo-like kinase 2 (Drosophila) 201939_at -2.47054478 Nucleus kinase ALDH3A1 aldehyde dehydrogenase 3 family, memberA1 205623_at -2.30532989 Cytoplasm enzyme TXNRD1 thioredoxin reductase 1 201266_at -2.27936909 Cytoplasm enzyme Extracellular CYR61 cysteine-rich, angiogenic inducer, 61 201289_at -2.09052668 Space other 214212_x_ FERMT2 fermitin family homolog 2 (Drosophila) at -1.87478183 Cytoplasm other Plasma RIT1 Ras-like without CAAX 1 209882_at -1.77586775 Membrane enzyme 210297_s_ Extracellular MSMB microseminoprotein, beta- at -1.72177723 Space other Extracellular PI3 peptidase inhibitor 3, skin-derived 203691_at -1.68135697 Space other ALDH3B1 aldehyde dehydrogenase 3 family, member B1 205640_at -1.67376791 Cytoplasm enzyme 202124_s_ Plasma TRAK2 trafficking protein, kinesin binding 2 at -1.6367793 Membrane transporter BMP and activin membrane-bound inhibitor Plasma BAMBI
    [Show full text]
  • The Borg Family of Cdc42 Effector Proteins Cdc42ep1–5
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Institute of Cancer Research Repository Biochemical Society Transactions (2016) 0 1–8 DOI: 10.1042/BST20160219 1 2 The Borg family of Cdc42 effector proteins 3 4 Cdc42EP1–5 5 6 Aaron J. Farrugia and Fernando Calvo 7 8 Tumour Microenvironment Team, Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW2 6JB, U.K. 9 Correspondence: Fernando Calvo ([email protected]) 10 11 12 13 Despite being discovered more than 15 years ago, the Borg (binder of Rho GTPases) 14 – family of Cdc42 effector proteins (Cdc42EP1 5) remains largely uncharacterised and rela- 15 tively little is known about their structure, regulation and role in development and disease. 16 Recent studies are starting to unravel some of the key functional and mechanistic 17 aspects of the Borg proteins, including their role in cytoskeletal remodelling and signal- 18 ling. In addition, the participation of Borg proteins in important cellular processes such as 19 cell shape, directed migration and differentiation is slowly emerging, directly linking Borgs 20 with important physiological and pathological processes such as angiogenesis, neuro- 21 fi transmission and cancer-associated desmoplasia. Here, we review some of these nd- 22 ings and discuss future prospects. 23 24 25 26 27 28 29 Introduction 30 The Rho GTPase family member Cdc42 regulates a diverse range of cellular functions including cyto- 31 kinesis, cytoskeletal remodelling and cell polarity [1,2]. Like other Rho family members, Cdc42 cycles 32 between two tightly regulated conformational states, a GTP-bound active state and a GDP-bound 33 inactive state [3].
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Mutations in Pi(3,5)P2 Signaling and Neurodegeneration in Mouse and Human
    MUTATIONS IN PI(3,5)P2 SIGNALING AND NEURODEGENERATION IN MOUSE AND HUMAN by Clement Y. Chow A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Human Genetics) in The University of Michigan 2008 Doctoral Committee: Professor Miriam H. Meisler, Chair Professor Sally A. Camper Professor David Ginsburg Associate Professor David C. Kohrman Assistant Professor Geoffrey G. Murphy Clement Y. Chow 2008 To my wife, Candace For all her love and support ii ACKNOWLEDGEMENTS I would first like to thank my mentor, Miriam Meisler. She is the consummate scientist. Miriam is inquisitive and interested in a wide range of topics. This trait has taught me to always ask the right questions and be skeptical of conclusions that are not supported by data. Miriam’s unending desire to make each oral presentation perfect drove me to improve my own skills. I came to this lab without any public presentation skills, but I am now greatly improved in my presentation abilities, a skill crucial for a successful scientific career. Miriam is a perfectionist when it comes to writing and always encouraged me to do the same. I will continue to strive to perfect my writing abilities. I came to the lab wanting to positionally clone a mouse mutant. I told Miriam that I would stay in the lab if she allowed me to do so. She was supportive and excited from the beginning, allowing me to pursue a project with an unknown future. This allowed me to learn, first hand, many aspects of genetics that such a project provides.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]